PTGS2 and neoplasm: To characterize the potential implications of COX-2/PGE2 signaling pathway in the IH-enhanced tumor growth and aggressiveness in the mouse model of OSA bearing LLC1 tumors, we employed Ce, a specific inhibitor of COX-2.